Rajah & Tann Singapore acted for Amsino Medical Group Company Limited in a substantial investment into Amsino by private equity firm Novo Tellus Capital Partners, and the subsequent exit of Amsino’s investors Jiangsu Yuwell Medical Equipment & Supply Company Limited and Jiangsu Yuwell Technology Development Company Limited via a share buyback carried out by Amsino. Amsino is a global designer and manufacturer medical devices and consumables, which are distributed to hospitals and other healthcare institutions worldwide, with key markets in the US and the PRC. Novo Tellus is a private equity firm specialising in long-term investments in the global supply chain. Partner Tan Mui Hui led the transaction.
Novo Tellus Capital Partners’ investment into Amsino and subsequent exit of Amsino’s investors
- Novo Tellus Capital Partners’ investment into Amsino and subsequent exit of Amsino’s investors